Cellectis and the Center for iPS Cells Research and Application enter collaboration
Cellectis and the Center for iPS Cells Research and Application (CiRA) of Kyoto University, Kyoto, Japan, have announced that they have started a scientific collaboration to combine Cellectis’ genome engineering technologies with CiRA’s induced pluripotent stem cell (iPS) technology to improve the natural characteristics of iPS cells for use as cellular tools.
CiRA was created in January 2008 by Kyoto University as part of an effort to advance iPS cells research. CiRA is headed by Prof Shinya Yamanaka, who pioneered iPS cells technology.
CiRA and Cellectis are planning to combine the iPS technology with the genome engineering expertise of Cellectis to rationally engineer the genome of these cells in order to provide better control over their behavior.
“This collaboration supports the approach developed by Cellectis with Ectycell, its subsidiary dedicated to the industrial uses of iPS cells,” declared David Sourdive, Executive Vice President, Corporate Development for Cellectis. “Together we believe we can maximize the natural synergy between these two complementary approaches to cell engineering, to develop technologies that could have a major impact in the stem cell field”.
Other news from the department science
